Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Zinc Hyaluronate to Prevent Keloid Recurrence after Excision
TCTR20220715001Phase 3Terminated
- Sponsor
- Faculty of Medicine
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zinc hyaluronate in keloid, sponsored by Faculty of Medicine. Started Jan 2013; status: terminated.
02
Drugs
zinc hyaluronate
03
Conditions
keloid
Beyond the preview
Go deeper on TCTR20220715001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220715001.